Physician profile
Simon G Tabchi
NPI 1366705238
$12,142.68
in general payments reported to CMS, 2019-2025
30 companies · $1,611 in 2025
The $1,611 reported for 2025 was more than what 79% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $865 · 2020: $900 · 2021: $1,663 · 2022: $1,735 · 2023: $4,099 · 2024: $1,271 · 2025: $1,611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,858 · Travel and Lodging: $2,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,858.13 |
| Travel and Lodging | $2,122.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,523.42 | 2019-2025 | Prostep, Augment Injectable, Salvation |
| Organogenesis INC. | $1,898.96 | 2019-2025 | Affinity, Puraply, Apligraf |
| Smith+Nephew, INC. | $1,402.80 | 2019-2025 | Grafix Pl, Stravix, Oasis Micro |
| Horizon Therapeutics Plc | $737.66 | 2020-2022 | |
| Convatec INC. | $487.36 | 2023-2025 | |
| Nevro Corp. | $224.76 | 2019-2024 | Senza |
| Paratek Pharmaceuticals, INC. | $206.30 | 2022-2025 | Nuzyra |
| Novus Surgical Solutions LLC | $144.27 | 2022 | |
| Globus Medical, INC. | $143.41 | 2025 | Senza |
| Kci USA, INC. | $141.55 | 2019-2023 | Activ.A.C., V.A.C.Instill |
| Novus Surgical Consultants | $139.78 | 2023 | |
| Depuy Synthes Sales INC. | $138.14 | 2019 | |
| Averitas Pharma INC. | $131.36 | 2023-2025 | Qutenza |
| Alexion Pharmaceuticals, INC. | $120.31 | 2022 | |
| Grt US Holding, INC. | $104.25 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $85.65 | 2019-2022 | |
| Next Science LLC | $80.54 | 2023-2025 | Blastx, Xperience, Surgx |
| Treace Medical Concepts, INC. | $77.31 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $59.32 | 2021 | |
| Misonix INC | $57.33 | 2021 | |
| Boston Scientific Corporation | $39.21 | 2025 | Wavewriter Alpha Prime 16 |
| Biocomposites INC | $38.14 | 2024 | |
| Reapplix INC. | $30.15 | 2022 | |
| Abbvie INC. | $28.06 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $24.10 | 2024 | |
| Orthofix Medical, INC. | $20.04 | 2021-2025 | Physio-Stim |
| Wright Medical Technology, INC. | $16.47 | 2020 | |
| Cashflow Solutions, LLC | $15.86 | 2022 | |
| Bone Support INC. | $14.22 | 2025 | Ceramentbone Void Filler, Cerament G |
| Synergy Orthopedics, LLC | $11.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Tabchi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.